Clin Orthop Surg.  2017 Mar;9(1):43-49. 10.4055/cios.2017.9.1.43.

Is Intraoperative Use of QuikClot Combat Gauze Effective for Hemostasis after Total Knee Arthroplasty?

• Noh JH
• Lee JW
• Nam YJ
• Choi KY

• KMID: 2412302
• DOI: http://doi.org/10.4055/cios.2017.9.1.43

Abstract

BACKGROUND
To assess the hemostatic effect of QuikClot Combat Gauze (QCG) compared to that of standard gauze during cruciate-retaining total knee arthroplasty (TKA).
METHODS
Sixty knees underwent TKA using a pneumatic tourniquet in this prospective randomized study. After implantation of the femoral and tibial components and hardening of the bone cement, the tourniquet was deflated and QCG (group 1) or standard gauze (group 2) was packed into the joint cavity for 5 minutes for hemostasis. Perioperative bleeding volume and blood transfusion volume were compared between two groups.
RESULTS
The mean intraoperative bleeding volume was 64.7 ± 12.7 mL in group 1 and 63.9 ± 9.2 mL in group 2 (p = 0.808). The mean postoperative blood drainage was 349.0 ± 170.6 mL in group 1 and 270.1 ± 136.3 mL in group 2 (p = 0.057). The average postoperative blood transfusion volume was 323.7 ± 325.9 mL in group 1 and 403.6 ± 274.8 mL in group 2 (p = 0.314).
CONCLUSIONS
QCG was not significantly effective for reducing perioperative bleeding volume or the blood transfusion rate compared with standard gauze during TKA.

Keyword

Knee; Replacement; Arthroplasty; Hemostasis; QuikClot Combat Gauze

MeSH Terms

Aged
Arthroplasty, Replacement, Knee/*adverse effects/methods
*Bandages
Blood Loss, Surgical/*prevention & control
Blood Transfusion
Blood Volume
Female
Hemostasis, Surgical/*instrumentation
Humans
Intraoperative Care
Male
Postoperative Hemorrhage/etiology/*prevention & control
Prospective Studies

Figure

• 

  Fig. 1 The Consolidated Standards Of Reporting Trials (CONSORT) flow diagram of this study. TKA: total knee arthroplasty.

Reference

1. Wu WC, Smith TS, Henderson WG, et al. Operative blood loss, blood transfusion, and 30-day mortality in older patients after major noncardiac surgery. Ann Surg. 2010; 252(1):11–17.

2. Glance LG, Dick AW, Mukamel DB, et al. Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology. 2011; 114(2):283–292.

3. Rawn J. The silent risks of blood transfusion. Curr Opin Anaesthesiol. 2008; 21(5):664–668.

4. Veien M, Sorensen JV, Madsen F, Juelsgaard P. Tranexamic acid given intraoperatively reduces blood loss after total knee replacement: a randomized, controlled study. Acta Anaesthesiol Scand. 2002; 46(10):1206–1211.

5. Orpen NM, Little C, Walker G, Crawfurd EJ. Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients. Knee. 2006; 13(2):106–110.

6. Hiippala S, Strid L, Wennerstrand M, et al. Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with total knee arthroplasty. Br J Anaesth. 1995; 74(5):534–537.

7. Sirker A, Malik N, Bellamy M, Laffan MA. Acute myocardial infarction following tranexamic acid use in a low cardiovascular risk setting. Br J Haematol. 2008; 141(6):907–908.

8. Johnson D, Bates S, Nukalo S, et al. The effects of QuikClot Combat Gauze on hemorrhage control in the presence of hemodilution and hypothermia. Ann Med Surg (Lond). 2014; 3(2):21–25.

9. Kheirabadi BS, Mace JE, Terrazas IB, et al. Safety evaluation of new hemostatic agents, smectite granules, and kaolin-coated gauze in a vascular injury wound model in swine. J Trauma. 2010; 68(2):269–278.

10. Arnaud F, Parreno-Sadalan D, Tomori T, et al. Comparison of 10 hemostatic dressings in a groin transection model in swine. J Trauma. 2009; 67(4):848–855.

11. Kellgren JH, Lawrence JS. Radiological assessment of osteoarthrosis. Ann Rheum Dis. 1957; 16(4):494–502.

12. Georgiadis AG, Muh SJ, Silverton CD, Weir RM, Laker MW. A prospective double-blind placebo controlled trial of topical tranexamic acid in total knee arthroplasty. J Arthroplasty. 2013; 28:8 Suppl. 78–82.

13. Lee SH, Cho KY, Khurana S, Kim KI. Less blood loss under concomitant administration of tranexamic acid and indirect factor Xa inhibitor following total knee arthroplasty: a prospective randomized controlled trial. Knee Surg Sports Traumatol Arthrosc. 2013; 21(11):2611–2617.

14. Notarnicola A, Moretti L, Martucci A, et al. Comparative efficacy of different doses of fibrin sealant to reduce bleeding after total knee arthroplasty. Blood Coagul Fibrinolysis. 2012; 23(4):278–284.

15. Seo JG, Moon YW, Park SH, Kim SM, Ko KR. The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2013; 21(8):1869–1874.

16. Wylie JD, Hartley MK, Kapron AL, Aoki SK, Maak TG. Failures and reoperations after matrix-assisted cartilage repair of the knee: a systematic review. Arthroscopy. 2016; 32(2):386–392.

17. Tsementzis SA, Hitchcock ER, Meyer CH. Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms: a double-blind placebo-controlled study. Acta Neurochir (Wien). 1990; 102(1-2):1–10.

18. Bae KC, Cho CH, Lee KJ, et al. Efficacy of intra-articular injection of thrombin-based hemostatic agent in the control of bleeding after primary total knee arthroplasty. Knee Surg Relat Res. 2014; 26(4):236–240.

19. Jeon SH, Kim JH, Lee JM, Seo ES. Efficacy of extramedullary femoral component alignment guide system for blood saving after total knee arthroplasty. Knee Surg Relat Res. 2012; 24(2):99–103.

20. Tavares Cardozo R, Fidelis de Souza Junior E, Campoli Alves W, Barbi Filho F. Total knee arthroplasty: indication of blood transfusion according to hematimetric variation and clinical symptoms of hypoperfusion. Rev Bras Ortop. 2014; 49(5):507–512.

21. Rosencher N, Kerkkamp HE, Macheras G, et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion. 2003; 43(4):459–469.

22. Borghi B, Casati A. Incidence and risk factors for allogenic blood transfusion during major joint replacement using an integrated autotransfusion regimen: the Rizzoli Study Group on Orthopaedic Anaesthesia. Eur J Anaesthesiol. 2000; 17(7):411–417.

23. Zhou Q, Zhou Y, Wu H, et al. Changes of hemoglobin and hematocrit in elderly patients receiving lower joint arthroplasty without allogeneic blood transfusion. Chin Med J (Engl). 2015; 128(1):75–78.

24. el-Nawawy A, Barakat S, Elwalily T, Abdel-Moneim Deghady A, Hussein M. Evaluation of erythropoiesis in protein energy malnutrition. East Mediterr Health J. 2002; 8(2-3):281–289.

25. Mitrache C, Passweg JR, Libura J, et al. Anemia: an indicator for malnutrition in the elderly. Ann Hematol. 2001; 80(5):295–298.

26. Abbott EM, Nandyala SV, Schwend RM. Does a kaolin-impregnated hemostatic dressing reduce intraoperative blood loss and blood transfusions in pediatric spinal deformity surgery? Spine (Phila Pa 1976). 2014; 39(19):E1174–E1180.

27. Johnson D, Westbrook DM, Phelps D, et al. The effects of QuikClot Combat Gauze on hemorrhage control when used in a porcine model of lethal femoral injury. Am J Disaster Med. 2014; 9(4):309–315.

28. Gegel B, Burgert J, Gasko J, et al. The effects of QuikClot Combat Gauze and movement on hemorrhage control in a porcine model. Mil Med. 2012; 177(12):1543–1547.